Why Chemed Stock Is Plummeting Today
(NYSE: CHE) -- home to hospice care provider Vitas Healthcare and Roto-Rooter -- saw its shares decline 9% as of 1 p.m. ET on Wednesday, according to data provided by S&P Global Market Intelligence.
Chemed reported second-quarter earnings that fell short of analysts' expectations, causing its share price to tumble.
While Chemed grew sales by 4% in Q2, adjusted earnings per share (EPS) declined by a staggering 22%. Meanwhile, management cut 2025 EPS guidance from $25.20 to $22.15, implying a 4% decline from last year's earnings.
Source Fool.com
Chemed Corp. Aktie
388,00 €
0,52 %
Deutliche Kaufsignale für Chemed Corp. mit mehreren Buy- und keinen Sell-Einschätzungen.
Die Community erwartet für Chemed Corp. ein Kursziel von 554 €, was eine deutliche Steigerung von über 20% gegenüber dem aktuellen Kurs von 388.0 € bedeuten könnte.
